Zhao LW, Sun J, Wang YY, Hua RM, Tai SC, Wang K, Fan Y. Prostate stromal tumor with prostatic cysts after transurethral resection of the prostate: A case report. World J Clin Cases 2021; 9(12): 2830-2837 [PMID: 33969066 DOI: 10.12998/wjcc.v9.i12.2830]
Corresponding Author of This Article
Kai Wang, PhD, Academic Fellow, Professor, Surgeon, Technical Editor, Department of Urology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, No. 261 Huansha Road, Hangzhou 310006, Zhejiang Province, China. kai_wang2015@163.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 26, 2021; 9(12): 2830-2837 Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2830
Prostate stromal tumor with prostatic cysts after transurethral resection of the prostate: A case report
Li-Wei Zhao, Ji Sun, Yu-Yong Wang, Run-Miao Hua, Sheng-Cheng Tai, Kai Wang, Yi Fan
Li-Wei Zhao, Department of Urology, School of Medicine, Hangzhou Normal University, Hangzhou 311121, Zhejiang Province, China
Ji Sun, Run-Miao Hua, Sheng-Cheng Tai, Yi Fan, Department of Urology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou 311202, Zhejiang Province, China
Yu-Yong Wang, Kai Wang, Department of Urology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Author contributions: Zhao LW and Sun J performed the case report and wrote the manuscript; Wang YY, Hua RM and Tai SC reviewed the literature; Wang K and Fan Y were the patient’s surgeons, supervised the work and edited the manuscript; All authors issued final approval for the version to be submitted.
Informed consent statement: Informed written consent was obtained from the patient, patient’s son and patient’s brother for publication of this report and any accompanying images obtained at the time of the investigations, but not at the time of writing the patient case report.
Conflict-of-interest statement: All authors declare that they have no conflicts of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kai Wang, PhD, Academic Fellow, Professor, Surgeon, Technical Editor, Department of Urology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, No. 261 Huansha Road, Hangzhou 310006, Zhejiang Province, China. kai_wang2015@163.com
Received: October 14, 2020 Peer-review started: October 14, 2020 First decision: December 21, 2020 Revised: January 18, 2021 Accepted: March 4, 2021 Article in press: March 4, 2021 Published online: April 26, 2021 Processing time: 183 Days and 0.6 Hours
Abstract
BACKGROUND
A prostatic stromal tumor is deemed to be a rare oncology condition. Based on the retrospective analysis of clinical data and scientific literature review, a case of prostatic stromal tumor was reported in this article to explore the diagnosis, treatment and prognosis of this rare disease.
CASE SUMMARY
The present case involved an older male patient who was admitted to our department for a medical consultation of dysuria. Serum prostate-specific antigen was 8.30 ng/mL, Ultrasound and magnetic resonance imaging suggested evident enlargement of the prostate and multiple cystic developments internally. Considering that the patient was an elderly male with a poor health status, transurethral resection of the prostate was performed to improve the symptoms of urinary tract obstruction. Furthermore, based on histopathologic examination and immunohistochemical staining, the patient was pathologically diagnosed with prostatic stromal tumor. The patient did not receive any further adjuvant therapy following surgery leading to a clinical recommendation that the patient should be followed up on a long-term basis. However, during the recent follow-up assessment, the patient demonstrated recurrence of lower urinary tract symptoms and gross hematuria.
CONCLUSION
Referring to scientific literature review, we believe that the management of these lesions requires a thorough assessment of the patient. Furthermore, the treatment of prostate stromal tumors should be based on the imaging examination and pathological classification. Active surgical treatment is of great significance to the prognosis of patients, and subsequent surveillance after the treatment is warranted.
Core Tip: The pathological type of this case was very rare. Few medical reports exist, so there is still a lack of high-level evidence to diagnose and treat this type of tumor. We hope to provide evidence for the diagnosis and treatment of prostate stromal tumors in the future.
